Omega Fund Management, LLC
CIK 0001637359
Annualised vol
17.922683%
Beta
0.137132
HHI
1980.271881
Top-10 weight
100.0%
VaR 95%
1.46813%
VaR 99%
3.550824%
Max drawdown
41.59598%
Matched value
85.17951%
Returns of reported holdings
Loading returns…
Position changes vs prior quarter
What the latest 13F shows bought and sold against the quarter before, by share count.
| Ticker | Change | Shares now | Shares before | Share change % | Value now ($) |
|---|---|---|---|---|---|
| BCAX | REDUCED | 1,822,150 | 2,392,150 | -23.83% | 54,099,634 |
| NUVB | UNCHANGED | 8,081,089 | 8,081,089 | 0.0% | 45,900,586 |
| BBOT | UNCHANGED | 3,289,661 | 3,289,661 | 0.0% | 25,067,217 |
| BBNX | UNCHANGED | 1,316,183 | 1,316,183 | 0.0% | 20,624,588 |
| ALMS | UNCHANGED | 241,255 | 241,255 | 0.0% | 6,788,916 |
| SANA | UNCHANGED | 843,750 | 843,750 | 0.0% | 2,944,688 |
| IMA | UNCHANGED | 455,361 | 455,361 | 0.0% | 2,686,630 |
| ODTX | NEW | 2,893 | - | - | 54,128 |
| REPL | CLOSED OUT | 0 | 248,672 | -100.0% | 0 |
Holdings (latest quarter)
| Ticker | Change | Issuer | Class | CUSIP | Value ($) | Weight % | Shares |
|---|---|---|---|---|---|---|---|
| BCAX | REDUCED | Bicara Therapeutics Inc. | Common Stock | 055477103 | 54,099,634 | 29.14 | 1822150.0 |
| NUVB | UNCHANGED | Nuvation Bio Inc. | Common Stock Class A | 67080N101 | 45,900,586 | 24.72 | 8081089.0 |
| - | Kestra Med Technologies Ltd | Common Stock | G52441105 | 26,003,471 | 14.0 | 1022149.0 | |
| BBOT | UNCHANGED | BridgeBio Oncology Therapeutics Inc. | Common Stock | 107924102 | 25,067,217 | 13.5 | 3289661.0 |
| BBNX | UNCHANGED | Beta Bionics Inc. | Common Stock | 08659B102 | 20,624,588 | 11.11 | 1316183.0 |
| ALMS | UNCHANGED | Alumis Inc. | Common Stock | 022307102 | 6,788,916 | 3.66 | 241255.0 |
| SANA | UNCHANGED | Sana Biotechnology, Inc. | Common Stock | 799566104 | 2,944,688 | 1.59 | 843750.0 |
| IMA | UNCHANGED | ImageneBio, Inc. | Common Stock | 45175G207 | 2,686,630 | 1.45 | 455361.0 |
| - | enGene Holdings Inc. | Common Stock | 29286M105 | 1,516,098 | 0.82 | 876357.0 | |
| ODTX | NEW | Odyssey Therapeutics Inc. | Common Stock | 67613T104 | 54,128 | 0.03 | 2893.0 |
Quarterly portfolios
| Period | Filed | Value ($) | Positions | Vol % | Beta | Max DD % |
|---|---|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | 185,685,956 | 10 | 17.922683 | 0.137132 | 41.59598 |
| 2026-03-31 | 2026-05-15 | 163,149,229 | 10 | 16.770653 | 0.12661 | 38.374979 |
| 2025-12-31 | 2026-02-17 | 286,520,062 | 11 | 15.543111 | 0.119986 | 36.20565 |
| 2025-09-30 | 2025-11-14 | 222,365,157 | 12 | 13.09628 | 0.107262 | 34.310342 |
| 2025-03-31 | 2025-05-15 | 169,462,464 | 13 | 14.614755 | 0.110612 | 36.690597 |
| 2024-12-31 | 2025-05-15 | 33,476,657 | 1 | 13.743738 | 0.029526 | 41.18291 |